Studies on development of a vaginal preparation providing both prophylaxis against venereal disease, other genital infections and contraception. 3. In vitro effect of vaginal contraceptive and selected vaginal preparations of Candida albicans and Trichomonas vaginalis
- PMID: 4568277
- DOI: 10.1016/0010-7824(72)90032-7
Studies on development of a vaginal preparation providing both prophylaxis against venereal disease, other genital infections and contraception. 3. In vitro effect of vaginal contraceptive and selected vaginal preparations of Candida albicans and Trichomonas vaginalis
Abstract
PIP: 41 preparations (jellies, creams, foams, etc.) were tested each in several dilutions with physiological saline for effect on inhibition of growth of C. albicans and T. vaginalis. 21 contraceptives and 20 noncontraceptives were employed. In both types of cultures, 1 method used to study growth involved mixing of preparation and organisms and intervals of 1, 5, or 10 minutes before inoculation of the medium, while the other method involved inoculation after the prepartion was added to the medium. These method types are referred to in the study as time exposure and dilution. Evaluation was 48 hours after start of incubation. The contraceptives effective (no growth) at some concentration from 10%-50% against C. albicans by the time-exposure method were the same contraceptives effective by the dilution method. They were Certane vaginal jelly, Lorophyn jelly, Contra foam, Lorophyn suppositories, Koromex A vaginal jelly, and Lanesta gel. Certane vaginal jelly was effective after exposure (interval after mixing and before inoculation) for 1 minute. Among the noncontraceptive preparations 10 were effective by the time-exposure method and an additional 4 were effective by the dilution method. In an associated test C. albicans was uninhibited by exposure up to 10 minutes in a pH of 2.2-10, thus casting out the possibility that the preparations are effective through pH. By the time exposure method all contraceptives were effective against T. vaginalis, most at a 1% concentration. All except 2 noncontraceptives were effective by both methods. The use of some of these preparations, contraceptive and noncontraceptive, might reduce the female's risk of contracting either infection during intercourse.
Similar articles
-
The effect of chemical intravaginal contraceptives and Betadine on Ureaplasma urealyticum.Contraception. 1984 Aug;30(2):135-41. doi: 10.1016/0010-7824(84)90097-0. Contraception. 1984. PMID: 6548687
-
Studies on the development of a vaginal preparation providing both prophylaxis against venereal disease and other genital infections and contraception. II. Effect in vitro of vaginal contraceptive and non-contraceptive preparations on Treponema pallidum and Neisseria gonorrhoeae.Br J Vener Dis. 1972 Feb;48(1):57-64. doi: 10.1136/sti.48.1.57. Br J Vener Dis. 1972. PMID: 4622671 Free PMC article.
-
The prevalence of Gardnerella vaginalis, Trichomonas vaginalis and Candida albicans in the cytology clinic at Ibadan, Nigeria.Afr J Med Med Sci. 1991 Mar;20(1):29-34. Afr J Med Med Sci. 1991. PMID: 1905467
-
Physiological aspects of vaginal contraception.Contraception. 1974 Apr;9(4):333-45. doi: 10.1016/0010-7824(74)90077-8. Contraception. 1974. PMID: 4613535 Review.
-
Nonbarrier contraceptives and vaginitis and vaginosis.Am J Obstet Gynecol. 1991 Oct;165(4 Pt 2):1240-4. doi: 10.1016/s0002-9378(12)90735-8. Am J Obstet Gynecol. 1991. PMID: 1951581 Review.
Cited by
-
Chlamydia trachomatis laboratory strains versus recent clinical isolates: implications for routine microbicide testing.Antimicrob Agents Chemother. 2009 Apr;53(4):1482-9. doi: 10.1128/AAC.01179-08. Epub 2009 Feb 2. Antimicrob Agents Chemother. 2009. PMID: 19188383 Free PMC article.
-
Decreased cervical epithelial sensitivity to nonoxynol-9 (N-9) after four daily applications in a murine model of topical vaginal microbicide safety.BMC Pharmacol Toxicol. 2012 Oct 1;13:9. doi: 10.1186/2050-6511-13-9. BMC Pharmacol Toxicol. 2012. PMID: 23025553 Free PMC article.
-
In vitro activity of nonoxynol 9 on HeLa 229 cells and primary monkey cervical epithelial cells infected with Chlamydia trachomatis.Antimicrob Agents Chemother. 1992 Jul;36(7):1478-82. doi: 10.1128/AAC.36.7.1478. Antimicrob Agents Chemother. 1992. PMID: 1324646 Free PMC article.
-
In vitro preclinical testing of nonoxynol-9 as potential anti-human immunodeficiency virus microbicide: a retrospective analysis of results from five laboratories.Antimicrob Agents Chemother. 2006 Feb;50(2):713-23. doi: 10.1128/AAC.50.2.713-723.2006. Antimicrob Agents Chemother. 2006. PMID: 16436731 Free PMC article.
-
Effects of nonoxynol-9 (N-9) on sperm functions: systematic review and meta-analysis.Reprod Fertil. 2022 Feb 21;3(1):R19-R33. doi: 10.1530/RAF-21-0024. eCollection 2022 Jan 1. Reprod Fertil. 2022. PMID: 35350652 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources